Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.
Menu

Hinrichs Lab - Publications

View Dr. Hinrichs' PubMed Summary.

  1. Nagarsheth NB, Norberg SM, Sinkoe AL, Adhikary S, Meyer TJ, Lack JB, Warner AC, Schweitzer C, Doran SL, Korrapati S, Stevanović S, Trimble CL, Kanakry JA, Bagheri MH, Ferraro E, Astrow SH, Bot A, Faquin WC, Stroncek D, Gkitsas N, Highfill S, Hinrichs CS. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat Med. 2021. Epub 2021/02/10. doi: 10.1038/s41591-020-01225-1. PubMed PMID: 33558725.
  2. Stevanovic S, Helman SR, Wunderlich JR, Langhan MM, Doran SL, Kwong MLM, Somerville RPT, Klebanoff CA, Kammula US, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS. A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial Cancers. Clin Cancer Res. 2019;25(5):1486-93. Epub 2018/12/07. doi: 10.1158/1078-0432.CCR-18-2722. PubMed PMID: 30518633; PMCID: PMC6397671.
  3. Marcinkowski B, Stevanovic S, Helman SR, Norberg SM, Serna C, Jin B, Gkitsas N, Kadakia T, Warner A, Davis JL, Rooper L, Hinrichs CS. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1. J Immunother Cancer. 2019;7(1):229. Epub 2019/08/29. doi: 10.1186/s40425-019-0678-x. PubMed PMID: 31455429; PMCID: PMC6712783.
  4. Doran SL, Stevanovic S, Adhikary S, Gartner JJ, Jia L, Kwong MLM, Faquin WC, Hewitt SM, Sherry RM, Yang JC, Rosenberg SA, Hinrichs CS. T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study. J Clin Oncol. 2019;37(30):2759-68. Epub 2019/08/14. doi: 10.1200/JCO.18.02424. PubMed PMID: 31408414; PMCID: PMC6800280.
  5. Jin BY, Campbell TE, Draper LM, Stevanovic S, Weissbrich B, Yu Z, Restifo NP, Rosenberg SA, Trimble CL, Hinrichs CS. Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model. JCI Insight. 2018;3(8). Epub 2018/04/20. doi: 10.1172/jci.insight.99488. PubMed PMID: 29669936; PMCID: PMC5931134.
  6. Stevanovic S, Pasetto A, Helman SR, Gartner JJ, Prickett TD, Howie B, Robins HS, Robbins PF, Klebanoff CA, Rosenberg SA, Hinrichs CS. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science. 2017;356(6334):200-5. Epub 2017/04/15. doi: 10.1126/science.aak9510. PubMed PMID: 28408606; PMCID: PMC6295311.
  7. Kang Z, Stevanovic S, Hinrichs CS, Cao L. Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring. Clin Cancer Res. 2017;23(22):6856-62. Epub 2017/09/14. doi: 10.1158/1078-0432.CCR-17-1553. PubMed PMID: 28899967; PMCID: PMC7885032.
  8. Stevanovic S, Draper LM, Langhan MM, Campbell TE, Kwong ML, Wunderlich JR, Dudley ME, Yang JC, Sherry RM, Kammula US, Restifo NP, Rosenberg SA, Hinrichs CS. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J Clin Oncol. 2015;33(14):1543-50. Epub 2015/04/01. doi: 10.1200/JCO.2014.58.9093. PubMed PMID: 25823737; PMCID: PMC4417725 online at www.jco.org. Author contributions are found at the end of this article.
  9. Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, Wunderlich JR, Somerville RP, Hogan K, Hinrichs CS, Parkhurst MR, Yang JC, Rosenberg SA. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014;344(6184):641-5. Epub 2014/05/09. doi: 10.1126/science.1251102. PubMed PMID: 24812403; PMCID: PMC6686185.
  10. Hinrichs CS, Rosenberg SA. Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol Rev. 2014;257(1):56-71. Epub 2013/12/18. doi: 10.1111/imr.12132. PubMed PMID: 24329789; PMCID: PMC3920180.